The Filing Desk

Elanco vs BeOne Medicines

Elanco ELAN · BeOne Medicines ONC · Pharmaceuticals

BeOne Medicines reported revenue of $5.3 billion in fiscal 2025, about the same as Elanco's $4.7 billion in fiscal 2025. Elanco's revenue grew 6.2% in its latest year, and BeOne Medicines' grew 40.2%. Free cash flow was $284 million at Elanco and $942 million at BeOne Medicines.

Side by side

ElancoBeOne Medicines
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$4.7B$5.3B
Revenue growth6.2%40.2%
Revenue growth a year, last 5 years7.6%76.8%
Gross margin55.0%87.5%
Operating margin—8.4%
Net margin−4.9%5.4%
Free cash flow$284M$942M
Free cash flow margin6.0%17.6%
Return on capital−0.1%25.8%
Net debt to EBITDA5.2x−6.3x
Dividends and buybacks$0M$0M
Change in diluted share count−0.2%7.8%
Last close$26.29$399.70
P/E at the last close——
Insider trades, last 12 monthsbought $2.6 million, sold $100,050sold $361.1 million
Piotroski F-score6 of 98 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
ElancoBeOne Medicines
Operating margin
Percent of revenue
ElancoBeOne Medicines
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
ElancoBeOne Medicines

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Elanco and BeOne Medicines pages.